138 related articles for article (PubMed ID: 18394641)
1. A scFv antibody fragment as a therapeutic candidate to neutralize a broad diversity of human IFN-alpha subtypes.
Depetris M; Casalis P; Kratje R; Etcheverrigaray M; Oggero M
J Immunol Methods; 2008 May; 334(1-2):104-13. PubMed ID: 18394641
[TBL] [Abstract][Full Text] [Related]
2. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
3. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors.
Kandefer-Szerszeń M; Lundgren E
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462
[TBL] [Abstract][Full Text] [Related]
4. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
[TBL] [Abstract][Full Text] [Related]
5. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
[TBL] [Abstract][Full Text] [Related]
6. [Improving the affinity of an anti-TNF-alpha scFv by random mutation].
Wang BA; Chen XS; Wang YX; Qu J; Zhou LJ; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):445-8. PubMed ID: 15989787
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to equine interferon-alpha (IFN-alpha): new tools to neutralize IFN-activity and to detect secreted IFN-alpha.
Wagner B; Hillegas JM; Flaminio MJ; Wattrang E
Vet Immunol Immunopathol; 2008 Oct; 125(3-4):315-25. PubMed ID: 18586327
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
9. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
10. [Production and characterization of the single chain antibodies against human alpha2b-interferon].
Okunev OV; Gil'chuk PV; Irodov DM; Deriabina EG
Ukr Biokhim Zh (1999); 2005; 77(5):106-15. PubMed ID: 16846077
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of a single-chain variable fragment antibody derived from a polyol-responsive monoclonal antibody.
Lamberski JA; Thompson NE; Burgess RR
Protein Expr Purif; 2006 May; 47(1):82-92. PubMed ID: 16216525
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing human anti-B-cell-activating factor of the TNF family (BAFF) scFv selected from phage antibody library.
Cao P; Xia Z; Song W; Zhang S
Immunol Lett; 2005 Oct; 101(1):87-94. PubMed ID: 15939481
[TBL] [Abstract][Full Text] [Related]
13. Preparation of Hybridomas producing monoclonal antibodies against human interferon.
Andzhaparidze OG; Nagieva FG; Pille ER; Nikulina VG; Barkova EP; Etkind GV; Melnikova NL; Khats YuS ; Sidorova EV
Acta Virol; 1988 Nov; 32(6):481-6. PubMed ID: 2906219
[TBL] [Abstract][Full Text] [Related]
14. Modification of the antigenic structure of human interferon alpha-2 by PH 2 treatment: a further support for the antigenic relationship between alpha and beta interferons.
Kontsek P; Borecký L; Koniseková E; Novák M; Krchnák V
Acta Virol; 1990 Apr; 34(2):145-54. PubMed ID: 1698015
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b].
Pavlova MV; Nikolaev IuS; Irodov DM; Okunev OV; Kordium VA; Gil'chuk PV
Tsitol Genet; 2008; 42(4):3-11. PubMed ID: 19140425
[TBL] [Abstract][Full Text] [Related]
16. In silico analysis of the structure of variable domains of mouse single-chain antibodies specific to the human recombinant interferon beta1b.
Flyak AI; Pavlova MV; Gilchuk PV
Tsitol Genet; 2009; 43(1):54-60. PubMed ID: 19663316
[TBL] [Abstract][Full Text] [Related]
17. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
18. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
[TBL] [Abstract][Full Text] [Related]
19. High efficiency recovery and epitope-specific sorting of an scFv yeast display library.
Siegel RW; Coleman JR; Miller KD; Feldhaus MJ
J Immunol Methods; 2004 Mar; 286(1-2):141-53. PubMed ID: 15087229
[TBL] [Abstract][Full Text] [Related]
20. A novel human scFv fragment against TNF-alpha from de novo design method.
Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
